Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
about
Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma.Targeting the androgen receptor in breast cancer.Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells.Identification of molecular apocrine breast tumours by microarray analysis.
P2860
Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Phase II clinical and endocrin ...... post-menopausal breast cancer.
@ast
Phase II clinical and endocrin ...... post-menopausal breast cancer.
@en
type
label
Phase II clinical and endocrin ...... post-menopausal breast cancer.
@ast
Phase II clinical and endocrin ...... post-menopausal breast cancer.
@en
prefLabel
Phase II clinical and endocrin ...... post-menopausal breast cancer.
@ast
Phase II clinical and endocrin ...... post-menopausal breast cancer.
@en
P2093
P356
P1476
Phase II clinical and endocrin ...... post-menopausal breast cancer.
@en
P2093
Cantwell BM
Carmichael J
Millward MJ
P2860
P2888
P304
P356
10.1038/BJC.1991.170
P407
P577
1991-05-01T00:00:00Z